Our production process for Type O Negative blood would represent a major advancement in medical science and healthcare delivery.
The production of Type O Negative blood would offer a safer, more reliable, and universally compatible option for blood transfusions.
It would have profound implications for healthcare, emergency medicine, and military operations, among other areas.
HematoGenesis™
Elimination of Blood Shortages with a Safe Alternative
Universal Donor Availability
Synthetic Type O Negative blood can be transfused to patients of any blood type, making it invaluable in mass casualty events, natural disasters, or battlefield injuries, saving more lives when time is of the essence.
Elimination of Blood Shortages
A supply would help alleviate blood shortages and ensure that blood banks have a consistent supply of a universally compatible blood type.
Reduction in Transfusion Reactions
Since Type O Negative blood is compatible with all recipients, the risk of hemolytic transfusion reactions, which occur when the recipient’s immune system attacks the transfused blood, would be eliminated.
Improved Safety
Blood can be designed to be free of variability and pathogens, reducing the risk of transmitting infections such as HIV, hepatitis, and other blood-borne diseases when relying on human donors.
Longer Shelf Life
Blood products may be engineered to have a longer shelf life than donated human blood, increasing global health equity and access in under-resourced or remote areas.